Search

Your search keyword '"Liu, Enli"' showing total 306 results

Search Constraints

Start Over You searched for: Author "Liu, Enli" Remove constraint Author: "Liu, Enli" Search Limiters Full Text Remove constraint Search Limiters: Full Text
306 results on '"Liu, Enli"'

Search Results

2. Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial

3. Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD

4. Author Correction: KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape

5. KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape

6. Phase I study of cord blood‐derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma

7. Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells

8. Large-scale GMP-compliant CRISPR-Cas9–mediated deletion of the glucocorticoid receptor in multivirus-specific T cells

10. A subset of virus-specific CD161+ T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML

11. Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering

13. IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation

14. Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation

17. Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD

19. Clinical responses with T lymphocytes targeting malignancy-associated κ light chains

20. Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+B cell tumors: a phase 1/2 trial

21. Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study

27. Epigenetic Scarring Leads to Irreversible NK Cell Dysfunction in Myeloid Malignancies

28. DAP10 Co-Stimulation Imparts Memory-like Features to CD5 Targeting Cord Blood Derived CAR-NK Cells

29. NK Cell Dysfunction in CLL Is Mediated through SHP-1 Signaling and Is Associated with Poor Prognosis

30. Generation and Screening of Various CD70 CAR NK Cells Identify the Most Effective Construct Against Hematologic Malignancies

31. CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients

32. Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells

33. Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies

34. Metabolic Reprogramming of GMP Grade Cord Tissue Derived Mesenchymal Stem Cells Enhances Their Suppressive Potential in GVHD

35. Overcoming CD226-related immune evasion in acute myeloid leukemia with CD38 CAR-engineered NK cells

36. Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

38. GMP-Compliant Universal Antigen Presenting Cells (uAPC) Promote the Metabolic Fitness and Antitumor Activity of Armored Cord Blood CAR-NK Cells

42. 531 AFM13-targeted blood and cord-blood-derived memory-like NK cells as therapy for CD30+ malignancies

47. Next Generation CRISPR Gene-Edited and Off-the-Shelf Virus-Specific T-Cells for the Immunocompromised Patient

48. Combining CAR Engineering and CIS Checkpoint Deletion in NK Cells for the Treatment of B Cell Hematologic Malignancies

49. Cord Blood Derived Natural Killer Cells Loaded with a Tetravalent Bispecific Antibody Construct (AFM13) As Off-the-Shelf Cell Therapy for CD30+ Malignancies

50. Manufacture of Clinical-Grade Universal Antigen Presenting Cells (UAPC) for the Ex Vivo Expansion and Activation of Natural Killer (NK) Cells

Catalog

Books, media, physical & digital resources